Bank of New York Mellon Corp
BankPosition in EBS — Emergent BioSolutions Inc.
CIK 1390777
NEW YORK, NY
Position in EBS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,840,757
+$55,902 QoQ
Shares Held
219,661
+2.1% QoQ
Ownership
0.428%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. EBS ranks #31 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in EBS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,840,757 | 219,661 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,784,855 | 215,043 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,022,167 | 244,512 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,352,438 | 153,338 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $901,574 | 141,313 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $82,632 | 17,003 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $115,761 | 12,109 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $101,109 | 12,109 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $430,172 | 170,029 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $425,247 | 177,187 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $813,816 | 239,358 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,554,290 | 483,577 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $5,221,840 | 504,039 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $6,184,658 | 523,680 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,120,619 | 482,164 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $14,954,260 | 481,774 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,195,792 | 589,279 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $25,685,854 | 590,887 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $29,750,987 | 594,188 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $32,909,563 | 522,457 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $46,946,862 | 505,294 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $46,611,349 | 520,216 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $55,635,965 | 538,430 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $42,678,522 | 539,688 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $30,639,296 | 529,542 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||